Latest News: Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreGLP-1 injections recalled across the US over sterility concernsGovt allows third-party agencies to conduct departmental inspectionsFridge-free vaccines could reach more people, but there are still practical challenges in African settingsLow Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of OsteoporosisHat Trick of PhDs in Health: Three Cheers for the Rare ResearcherMinistry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra viresSecond Documented Case of Pan-Drug Resistant Candida auris Uncovered in KenyaAstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovationPharmaceuticals export reports around 4.9 per cent growth in H1 FY27NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos PortTwo More Pregnant Women In Rajasthan’s Kota Die From Kidney ComplicationsCancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000Fake beauty products with ₹6.9L face value seized from two shops; owners arrestedMankind Pharma to Acquire 70% Stake in Belgium’s ACTxCan a drug licence be suspended before a hearing? Karnataka HC explains ruleA Boy survives 18th Floor Fall, thanks to Yashoda MedicityAstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sitesFDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplashSun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone GraftingGovernments have moved for Price Transparency in Hospitals to help patients cope with billsThe Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney DysfunctionThree arrested after liquor bottles found at pharma firmNEXUS 2026 brings pharma experts together to explore next generation analytical technologiesNational Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory DiscrepancySix leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health DayCancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: SourcesGujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two9,800 psychotropic tablets worth ₹2.53 crore seized in Mumbai’s GovandiStory of Bariatric Surgery Joining One Family’s Battle Against Severe ObesityMaharashtra FDA Cancels Three Cadila Pharma Licences Over Aciloc, Aciloc+ Drug Mix-Up RiskNational Institute of Nutrition study finds strong link between diet quality and Rheumatoid ArthritisSIT raids three Bengaluru pharmacies, traces trail of fake medicine salesKarnataka High Court stays drug licence suspension, cancellation ordersCCB books case over fake face wash sold on online marketplace2 diagnostic centres in Nirmal sealed for violating rulesIndian Healthcare is abysmally Deficient in its ability to cater to Impending Tsunami of SeniorsUP orders price transparency in hospital pharmaciesTG SAFE drug wing raids medical shop in Sangareddy, seizes illegal tramadol worth Rs. 58,904FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences LtdAt least five workers killed in boiler explosion at pharma unit in Andhra Pradesh’s Sri City SEZUnauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar storesFSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’Meet Samrat of Robotic Surgery, poised to bring Dawn of Cutting-edge Healthcare in BiharPushpanjali Medicon: ‘No Lunch Break’ Marathon of Medical Matters4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from dutyDelhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinksHaryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CMIndian speciality drugs get zero duty as US widens 100% tariff on patented medicinesLow-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARCKrsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 croreSN Genelab buy gives Dr Lal PathLabs specialised genomics tests and a bigger western India baseMaharashtra pharmacy first CAP list opens 28,139 B.Pharm, Pharm.D admissions in 528 colleges: CET CellNMC releases PG medical seat matrix for 2026-27, warns colleges against admissions beyond intakeNEET-UG may move online as Education Ministry drafts national CBT infrastructure planSandur Manganese enters medical devices with wholly owned unit Royal Sandur MedTechRussian PCR equipment maker DNA Technology plans first overseas factory in Uttar PradeshDTAB recommends licence exemptions for home-use medical devices and first-aid kits: ReportMolbio Diagnostics shares rise 9% after Jefferies starts coverage with buy rating: reportSun Pharma plans Rs 10,000 crore rupee bond sale to refinance Organon bridge loan: sourcesIHH to raise Fortis Healthcare stake to 51% over three to five years: exchange filingMukh Mantri Sehat Bima Yojana to cover 65 lakh families in Punjab: Kuldeep DhaliwalPFRDA to launch NPS Swasthya with super top-up health insurance cover this weekInsurers must compete on price and product quality, not distributor payouts: Irdai chiefLupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tabletsCentre can invoke Patents Act to make costly patented cancer drugs affordable: Kerala High CourtSun Pharma licenses cholesterol drug lerodalcibep from LIB Therapeutics for markets outside US, ChinaSafdarjung Hospital performs its first dual kidney transplant using organs from marginal donorHospital stocks slide up to 6% after Supreme Court flags drug mark-ups at corporate hospitalsMedanta buys Rs 166 crore land parcel in Ghaziabad to build 350-bed tertiary care hospitalU.S. says two Indian nationals indicted in counterfeit Ozempic smuggling schemeAsian Institute of Medical Sciences red flags threat of Drug- Resistant SuperbugsYashoda Medicity goes the Whole Nine Yards to tackle Cardiac EmergenciesHeart disease is no longer an age-defined illness: ExpertsKingpin of counterfeit pharma racket arrested at Bengaluru airport after Sharjah returnChild rights panel seeks report on measles deaths in Keralam’s MalappuramCancer, kidney, AIDS drugs sold at up to 70 times procurement cost: Karnataka Health MinisterCDSCO steps up scrutiny of pharma drugs containing narcotic substancesInquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DMMedical devices PLI scheme drives local output of MRI, CT scanners, heart valves: CentreMPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11Arogya Manthan 2026 to launch new digital health and health assurance initiativesBengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 heldBanned in India, sold in Maharashtra: Man held over fake Pakistani beauty creamGreen or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-vegCounterfeit rabies vaccine worth ₹2 lakh seized in DelhiAIIA organises public awareness rally on 11th Ayurveda DayUKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugsCDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillanceFSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depotExcellence of Accredited Hospitals to be judged on how Friendly they are with PatientsWHO launches new primary health care course to strengthen health systems globallyAyurveda needs stronger evidence, safety monitoring for market adoption, says CCRASYashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old WomanAvacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironmentUS FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type ATechnology and accessibility are key to growth of advanced treatment of heart diseases, says expertPuresta launches EVERQ, AI-powered skin-health platform
October 27, 2026
Latest News: Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreGLP-1 injections recalled across the US over sterility concernsGovt allows third-party agencies to conduct departmental inspectionsFridge-free vaccines could reach more people, but there are still practical challenges in African settingsLow Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of OsteoporosisHat Trick of PhDs in Health: Three Cheers for the Rare ResearcherMinistry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra viresSecond Documented Case of Pan-Drug Resistant Candida auris Uncovered in KenyaAstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovationPharmaceuticals export reports around 4.9 per cent growth in H1 FY27NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos PortTwo More Pregnant Women In Rajasthan’s Kota Die From Kidney ComplicationsCancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000Fake beauty products with ₹6.9L face value seized from two shops; owners arrestedMankind Pharma to Acquire 70% Stake in Belgium’s ACTxCan a drug licence be suspended before a hearing? Karnataka HC explains ruleA Boy survives 18th Floor Fall, thanks to Yashoda MedicityAstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sitesFDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplashSun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone GraftingGovernments have moved for Price Transparency in Hospitals to help patients cope with billsThe Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney DysfunctionThree arrested after liquor bottles found at pharma firmNEXUS 2026 brings pharma experts together to explore next generation analytical technologiesNational Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory DiscrepancySix leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health DayCancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: SourcesGujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two9,800 psychotropic tablets worth ₹2.53 crore seized in Mumbai’s GovandiStory of Bariatric Surgery Joining One Family’s Battle Against Severe ObesityMaharashtra FDA Cancels Three Cadila Pharma Licences Over Aciloc, Aciloc+ Drug Mix-Up RiskNational Institute of Nutrition study finds strong link between diet quality and Rheumatoid ArthritisSIT raids three Bengaluru pharmacies, traces trail of fake medicine salesKarnataka High Court stays drug licence suspension, cancellation ordersCCB books case over fake face wash sold on online marketplace2 diagnostic centres in Nirmal sealed for violating rulesIndian Healthcare is abysmally Deficient in its ability to cater to Impending Tsunami of SeniorsUP orders price transparency in hospital pharmaciesTG SAFE drug wing raids medical shop in Sangareddy, seizes illegal tramadol worth Rs. 58,904FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences LtdAt least five workers killed in boiler explosion at pharma unit in Andhra Pradesh’s Sri City SEZUnauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar storesFSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’Meet Samrat of Robotic Surgery, poised to bring Dawn of Cutting-edge Healthcare in BiharPushpanjali Medicon: ‘No Lunch Break’ Marathon of Medical Matters4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from dutyDelhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinksHaryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CMIndian speciality drugs get zero duty as US widens 100% tariff on patented medicinesLow-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARCKrsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 croreSN Genelab buy gives Dr Lal PathLabs specialised genomics tests and a bigger western India baseMaharashtra pharmacy first CAP list opens 28,139 B.Pharm, Pharm.D admissions in 528 colleges: CET CellNMC releases PG medical seat matrix for 2026-27, warns colleges against admissions beyond intakeNEET-UG may move online as Education Ministry drafts national CBT infrastructure planSandur Manganese enters medical devices with wholly owned unit Royal Sandur MedTechRussian PCR equipment maker DNA Technology plans first overseas factory in Uttar PradeshDTAB recommends licence exemptions for home-use medical devices and first-aid kits: ReportMolbio Diagnostics shares rise 9% after Jefferies starts coverage with buy rating: reportSun Pharma plans Rs 10,000 crore rupee bond sale to refinance Organon bridge loan: sourcesIHH to raise Fortis Healthcare stake to 51% over three to five years: exchange filingMukh Mantri Sehat Bima Yojana to cover 65 lakh families in Punjab: Kuldeep DhaliwalPFRDA to launch NPS Swasthya with super top-up health insurance cover this weekInsurers must compete on price and product quality, not distributor payouts: Irdai chiefLupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tabletsCentre can invoke Patents Act to make costly patented cancer drugs affordable: Kerala High CourtSun Pharma licenses cholesterol drug lerodalcibep from LIB Therapeutics for markets outside US, ChinaSafdarjung Hospital performs its first dual kidney transplant using organs from marginal donorHospital stocks slide up to 6% after Supreme Court flags drug mark-ups at corporate hospitalsMedanta buys Rs 166 crore land parcel in Ghaziabad to build 350-bed tertiary care hospitalU.S. says two Indian nationals indicted in counterfeit Ozempic smuggling schemeAsian Institute of Medical Sciences red flags threat of Drug- Resistant SuperbugsYashoda Medicity goes the Whole Nine Yards to tackle Cardiac EmergenciesHeart disease is no longer an age-defined illness: ExpertsKingpin of counterfeit pharma racket arrested at Bengaluru airport after Sharjah returnChild rights panel seeks report on measles deaths in Keralam’s MalappuramCancer, kidney, AIDS drugs sold at up to 70 times procurement cost: Karnataka Health MinisterCDSCO steps up scrutiny of pharma drugs containing narcotic substancesInquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DMMedical devices PLI scheme drives local output of MRI, CT scanners, heart valves: CentreMPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11Arogya Manthan 2026 to launch new digital health and health assurance initiativesBengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 heldBanned in India, sold in Maharashtra: Man held over fake Pakistani beauty creamGreen or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-vegCounterfeit rabies vaccine worth ₹2 lakh seized in DelhiAIIA organises public awareness rally on 11th Ayurveda DayUKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugsCDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillanceFSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depotExcellence of Accredited Hospitals to be judged on how Friendly they are with PatientsWHO launches new primary health care course to strengthen health systems globallyAyurveda needs stronger evidence, safety monitoring for market adoption, says CCRASYashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old WomanAvacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironmentUS FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type ATechnology and accessibility are key to growth of advanced treatment of heart diseases, says expertPuresta launches EVERQ, AI-powered skin-health platform
October 27, 2026

AstraZeneca Pharma India gets DCGI nod to market cancer drug in India

New Delhi: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets used for the treatment of ovarian and breast cancer. The permission from the DCGI is for olaparib (Lynparza) tablets in the strengths of 100 mg and 150 mg, AstraZeneca Pharma India said in a BSE filing.

The tablets are a patented product of the AstraZeneca group, it added.

“The import and market permission for olaparib is a significant milestone for women in India living with platinum-sensitive relapsed ovarian cancer and BRCA-mutated HER-2 negative metastatic breast cancer, which has historically been difficulty-to-treat diseases,” AstraZeneca Pharma India MD Gagan Singh said.

Shares of AstraZeneca Pharma India today closed at Rs 1,710.30 per scrip on BSE, up 1.59 per cent from their previous close.

    • admin

    Related Posts

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore
    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    Mankind Pharma shares jumped nearly 8% on Tuesday to an intraday high of Rs 2,500 on the NSE after the company reported a 38% year-on-year rise in Q2 profit after…

    Continue reading
    GLP-1 injections recalled across the US over sterility concerns
    GLP-1 injections recalled across the US over sterility concerns

    A nationwide recall of compounded tirzepatide injections in the United States has raised fresh concerns about the safety of weight-loss medicines. The recall, initiated by Apothecary Pharma LLC over concerns…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    GLP-1 injections recalled across the US over sterility concerns

    GLP-1 injections recalled across the US over sterility concerns

    Govt allows third-party agencies to conduct departmental inspections

    Govt allows third-party agencies to conduct departmental inspections

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher